WeylChem Acquires Catexel Businesses

WeylChem Acquires Catexel Businesses
WeylChem Acquires Catexel Businesses

International Chemical Investors Group (ICIG) and WeylChem Group together have acquired the Home Care, Cellulosics and Synthesis business of Catexel Group from Unilever Ventures.

With the buy WeylChem said it is broadening its portfolio of performance chemicals, thus gaining access to additional markets in industrial & institutional cleaning, textile bleaching, pulp bleaching and process technologies. The buy strengthens its leading position as supplier and manufacturer of oxidation catalysts and bleach activators, it added.

The transaction, which comprises the intellectual property of Catexel for a variety of applications, aso increases the innovation capabilities of the combined businesses through its dedicated R&D team, the German group said.

Andreas Maier, managing director of WeylChem Performance Products and head of the Consumer Care business unit, said the combination of its own and Catexel’s capabilities “creates a leading global expert in the field of oxidation catalysis.”

For ICIG, managing director Achim Riemann commented that the purchase fits well with its strategy to enhance its platforms by supporting add-on acquisitions.

Company

Logo:

WeylChem International GmbH

Alt-Fechenheim 34
60386 Frankfurt
Germany

Company contact







CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.